Source: Chris Parry, Stockhouse.com, April 17 2014
On significantly lower volume than was seen earlier in the month, companies are beginning to move up on news of confirmed business rather than raising a hand and saying words like ‘agriculture, tech and biomed opportunities’.
Enertopia (CSE:C.TOP, Stock Forum) announced today it is generating revenue from warrants and option exercising, as two of its joint venture projects, World of Marihuana and Green Canvas continue their licensing/build-out plans. They’ve also added Jeff Paikin, President of the New Horizon Development Group, to their advisory board in return for 400k+ shares. Not sure what value a real estate developer brings to the group, but it can’t hurt.
Enertopia has made a habit of jumping into the plans of other companies rather than putting all their eggs in one basket, which will likely result in a couple of dropped balls along the way but also some home runs.
In a sector that, at this point, could see any company turn turtle if they have a Health Canada licensing slip-up, diversity isn’t a bad plan. That said, I’ve also heard from several industry insiders that Enertopia management is very promotional and not so detail oriented, so expect to see plenty more profitable stock volatility in the weeks ahead but use your own due diligence if you’re looking at it as a long hold.
Enertopia is up 23% on the day, 73% in the last two days, and 350% since January 1, though it is down over 50% from its mid-March high of $1.00.
With volatility like that, Enertopia is the nitro-glycerine of the dot.bong world.
One of the medical marijuana markets big issues over the last month or two has been establishing legitimacy in the eyes of big investors. With Growlife (OBB:PHOT, Stock Forum) currently SEC-stomped and Advanced Cannabis Solutions (CANN) having been face-palmed by the feds weeks earlier, the recent two-day weed stock crisis came firmly out of suspicions that some large ganjcos were (no pun intended) smoke and mirrors, and were about to be found out.
So what does Creative Edge (OTO:FITX, Stock Forum) partner CEN Biotech do to fight that idea? They hire a 33-year veteran banker, securities fraud examiner, and IRS whistleblower as their new Chairman of the Board.
Which is kind of like having Bill Gates check your computer science homework.
If anyone had wondered if Creative Edge and co. had been playing fast and loose with trades or paperwork, chances are they’re not wondering anymore. And their recent lightning quick decision to sever all ties with Growlife, a company that stands suspected by the SEC of having cut corners in trades and accounting, doubles down on the credibility front.
Creative Edge is already a $267.7 million market cap player with 3.4 billion shares outstanding, so they might not be in the sights of the Canadian daytrading penny play crowd, but as an example of how to de-risk your game, they’ve set a solid example for others.
The market agrees: FITX is up 23.5% today, building up off a dip.
Seaway Energy Services (TSX:V.SEW, Stock Forum) has been trade-halted, at the company’s request, with pending news. Seaway shares have quietly and consistently climbed to a near 52-week high of $0.34, up from $0.10 in early March when it announced it was becoming a potco. It has an ultra-tight share structure and just a $1.4m market cap, so if the news coming is brand-building in nature, holders are about to be VERY happy.
Also trade-halted is Supreme Pharmaceuticals (TSX:V.SL, Stock Forum), though this one is ‘pending review of change of business,’ which has had Chlormet stock tied up for over a week now and could see a long delay while paperwork is filed and reviewed.
Tweed (TSX:V.TWD, Stock Forum) is showing some wild swings in price over the last week, with the company having gone from $3.60 down to $2.40, and now back to $3.40 in just the last five trading days. Other than a deal to bring a brand of vaporizers into the Tweed customer offerings, there’s been no news to warrant that kind of movement in either direction.
Considering their turns have matched the US sector’s crazy run of late, it likely points to that company having a large US investor base that should be considered by Canadian buyers going forward. If the US sector hits another snag, Tweed will feel it more than, say, Affinor or Seaway. Today, they’re up 12%.
In the US, as the dust settles on the Great Weed Short War, AvWorks Aviation (OTO:SPLI, Stock Forum) has, as I predicted, flown upwards. Having been horrifically oversold from $0.45 back to $0.05 over a little more than a week, it has jumped 30.9% today to $0.12, with plenty more room to move.
The company will be competing in the Cannabis Cup at the Colorado-based High Times conference coming up, which one Vancouver broker tells me he’s attending, despite it being sold out, because he found tickets on StubHub.
Think back only a year ago, when a collection of Colorado weed smokers would likely soon end up with felonies to their names – now we’re buying tickets to weed conferences (that, in this case, includes a ‘smokers pit’ on the convention floor) on freakin’ StubHub.
I’ve pretty much ignored Jouran Resources (TSX:V.JOR, Stock Forum) since they’ve joined the bud hub-bub, because I’m just not so big on the prospects of fertilizer plays attached to the mary jane market. I’d rather see a fertilizer company sell a billion tonnes of product to Con-Agra than a few sacks of phosphate at a time to Satori Resources, but credit where it’s due, Jourdan is making solid moves that could make them the first genuine two-sector play in this space.
Jourdan announced today they’ve acquired a 100% interest in the Picnic Phosphate project in Quebec. The twist on that area is they’re more than a little likely to find themselves yanking iron, titanium, copper, nickel and cobalt out of the ground as they’re going in for the phosphate.
The company already has a ‘growth media and slow release natural phosphate fertilizer’ testing arrangement with ChroniCare Canada, but their mineral exploration strategy continues moving forward, so my reading of this company isn’t that they’re a stoner-come-lately; more that they’re finding a genuine middle ground between mining and medical marijuana that could see them dive in on either end of the equation, depending on how the next six months go.
Alternately, they may find revenue on both ends of the deal which would be a great upside. The company is up 14.2% today.
Rango Energy (OTCQB:RAGO, Stock Forum) has been crawling California, I’m told, looking for medical marijuana patient-facing acquisitions. Stock is up 17.6% today on the news the company is focusing on delivering ‘integrated patient healthcare solutions’.
I *think* this means they’re looking to buy clinics and create a franchise of sorts, but your guess is as good as mine based on the following:
“We intend Verde Science [Rango’s soon-to-be name] to be one of the initial corporate players in the medical marijuana industry that currently lacks sophistication, controls, standards and innovation. Verde is assembling a highly experienced team that will deploy state-of-the-art technology and a superior methodology to enter and take meaningful market share that can be repeated and expanded as more and more jurisdictions adopt legal use of cannabis products to address health care issues. But we want to stress that we are being meticulous, measured and diligent and as we move forward with an absolute focus on compliance while offering the patient community unsurpassed, fully integrated, holistic health care programs.”
That plan makes sense but for, in my opinion, two reasons. First, they’re late to an already hugely well-established market that, although fragmented, isn’t likely to experience the kind of growth other areas will in the coming years.
My second caution on the Rango plan is, hey, weed is still illegal on a federal level, and California dispensaries, though perfectly legal and regulated on a state level, are still subject to raids, shutdowns and seizures by federal officers, which fail to recognize medical marijuana as being legal.
Also worth noting, it’s illegal to profit from marijuana sales in California, so Verde would need to find ancillary ways to make money.
For a public company, a federal raid would be devastating, which is why nobody has de-fragmented this market to this point. You wanna be the Subway of weed? You better hope the federal stance on medical marijuana changes soon.
Chicago-based would-be potcos are annoyed that, in order to be considered for legal growing, you need to front “a $2 million surety bond, $250,000 in liquid assets, $25,000 for an application fee, $200,000 for a permit fee and an approved site,” according to a Chicago Tribune story. Then you have to actually build out the facility…
Interview with the owner of the private MMPR holder MedReleaf at the Toronto Star is a good read.
A Vancouver Sun blog post by pot activist Dana Larsen makes a good point about Health Canada language screwing over marijuana patients: Because HC won’t call it a prescription, but rather ‘doctor permission’, “Doctors aren’t allowed to charge extra to write a prescription, but they can legally demand an arbitrary fee to fill out paperwork like a medical marijuana access form. Since they aren’t “prescribing” it, doctors can and do charge a few hundred bucks for patients who need access to cannabis medicine.”
Naturally Splendid (TSX:V.NSP, Stock Forum) jumped 25% in late trading with no news to accompany the rise. That company’s CEO made contact with me in the last few days with an invitation to come snoop around and chat about their plans, which I hope to take them up on in a week or so. They’re pushing into the hemp-based health food space and have some distribution deals in the works, and they recently appointed the former CEO of Arrowhead Water to their advisory board. Legit.